Wound care products developed for sports segment
Life sciences company Quick-Med Technologies has signed a new deal with medical device company Biosara Corporation. Under the terms of the agreement, Quick-Med will develop an antimicrobial wound dressing designed specifically for the organised sports segment of the institutional wound care market.
Quick-Med received an initial payment upon entering into the agreement and will receive additional payments to fully fund the project during the six months the development is expected to take.
"We are pleased to be working with Quick-Med on development of a new antimicrobial wound dressing," said Ted Pappas, president and CEO of Biosara. "Our market research shows there's a large demand for the Active Armor product line that's being developed. Our extensive relationships in the global medical community and the professional sports arena have consistently expressed the need for next generation antimicrobials and other innovative solutions leading to lower infection rates, lower wound care costs, and less pain."
